Galapagos NV (GLPGF)
PNK: GLPGF
· Real-Time Price · USD
22.39
0.00 (0.00%)
At close: Apr 30, 2025, 8:00 PM
0.00% (1D)
| Bid | 22.39 |
| Market Cap | 1.48B |
| Revenue (ttm) | 288.19M |
| Net Income (ttm) | -169.54M |
| EPS (ttm) | -3.11 |
| PE Ratio (ttm) | -7.2 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 27.79 |
| Volume | 190 |
| Avg. Volume (20D) | 1 |
| Open | 26.20 |
| Previous Close | 22.39 |
| Day's Range | 22.39 - 26.20 |
| 52-Week Range | 22.39 - 26.91 |
| Beta | -0.01 |
About GLPGF
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative colitis, small bowel CD, fistulizing CD, ankylosing spondylitis, psoriatic arthritis, and uveitis. The compan...
Industry Biotechnology
Sector Healthcare
IPO Date Aug 3, 2009
Employees 704
Stock Exchange PNK
Ticker Symbol GLPGF
Website https://www.glpg.com